Hepion Pharmaceuticals to Present on CRV431 and AI-POW(TM) at NASH-TAG 2021
EDISON, NJ / ACCESSWIRE / March 11, 2021 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)("Hepion"), a clinical stage biopharmaceutical company focused on...
Year: 2021
DORA Biological Anti-Virus Mask of HILORS with a Viral Filtration Efficiency VFE>99.9a % unveiled
NEW YORK, NY / ACCESSWIRE / March 11, 2021 / DORA Biological Anti-Virus Mask is the world's leading virus-blocking biological...
Zealand Pharma: on Track for Potential First Product Launch and Establishing Commercial Operations in the United States
Company announcement – No. 12 / 2021 Zealand Pharma: on Track for Potential First Product Launch and Establishing Commercial Operations...
Gritstone Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights
EMERYVILLE, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation...
Bioventus Reports First Patients Enrolled in Phase 1 Clinical Trial of MOTYS™ (PTP-001) for the Treatment of Knee OA
DURHAM, N.C., March 11, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in solutions...
Philips, American College of Cardiology and MedAxiom collaborate to shape the future of cardiovascular care delivery
Philips Azurion TAVI procedure Philips Azurion with EPIQ CVxi March 11, 2021 Organizations to develop roadmap for hospitals, health systems...
Longeveron’s Lomecel-B™ Approved by FDA for Compassionate Use for the Treatment of Child with Hypoplastic Left Heart Syndrome (HLHS)
MIAMI, March 11, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing...
Renibus Therapeutics Initiates Phase 2 Study of RBT-1 for Prevention of Acute Kidney Injury
- The Phase 2 study will evaluate the efficacy of RBT-1 on acute kidney injury prevention in subjects undergoing cardiac...
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033
MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research,...
Pure Extracts Sells First Shipment of Cannabis Oil Extracts to German Pharma Company
VANCOUVER, British Columbia, March 11, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Avicanna to present at the Q1 Virtual Investor Summit
TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire- Avicanna (AVCNF) today announced that Aras Azadian, CEO, will be attending...
Avinger, Inc. to Present at the Q1 Virtual Investor Summit
REDWOOD CITY, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire- Avinger, Inc. (Nasdaq: AVGR), commercial-stage medical device company marketing...
CorMedix Inc. Announces Contract Extension of Liz Masson-Hurlburt as Executive Vice President and Head of Clinical Operations
BERKELEY HEIGHTS, N.J., March 11, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company focused on developing and...
Entera Bio Ltd Announces Positive Topline EB613 Phase 2 Biomarker Data
‒ Trial Met Primary Endpoint of Significant Increase in P1NP Based on Final Analysis of 3 Month Data ‒‒ Final...
Bellerophon Provides Clinical Program Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
WARREN, N.J., March 11, 2021 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics...
PDS Biotech Announces that its COVID-19 Vaccine Consortium Received a Commitment from The Ministry of Science, Technology and Innovation of Brazil (MCTI) to fund Clinical Development and Commercialization of a Versamune®-Based COVID-19 Vaccine with an Award of up to Approximately US$60 million
Development and commercialization of novel T-cell activating vaccine to be performed in Brazil by consortium of PDS Biotech, Farmacore Biotechnology...
Denali Therapeutics Announces Fast Track Designation Granted by the U.S. FDA to ETV:IDS (DNL310) for the Treatment of Patients with Hunter Syndrome (MPS II)
SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a...
VistaGen’s PH10 Nasal Spray Demonstrates Different Mechanism of Action from Benzodiazepines in Preclinical Study
PH10 may have stand-alone potential to displace current oral antidepressants in the drug treatment paradigm for depression disordersSOUTH SAN FRANCISCO,...
SELLAS Life Sciences to Participate in the M Vest and Maxim Group Inaugural Emerging Growth Virtual Conference on March 17th
NEW YORK, March 11, 2021 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) ("SELLAS" or the “Company”), a...
Yield10 Bioscience to Present at Maxim Group’s 2021 Inaugural Emerging Growth Virtual Conference
WOBURN, Mass., March 11, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announces that Chief...